Patent · US Active

5-membered annelated heterocyclic pyrimidines as kinase inhibitors

US7947695B2 · kind B2 · utility

3Cited by

0References

19Claims

0Family size

Assignee

Janssen Pharmaceuticals, Inc. · BE

Inventors

Eddy Jean Edgard Freyne · Rumst, BE
Jean Fernand Armand Lacrampe · Le Mesnil-Esnard, FR
Timothy Pietro Suren Perera · Felton, GB
Peter Ten Holte · Beerse, BE
Yannick Aime Eddy Ligny · Sotteville-lès-Rouen, FR
Delphine Yvonne Raymonde Lardeau · Issy-les-Moulineaux, FR
Tom Lavrijssen · Vosselaar, BE

Key dates

Filing date	Jan 9, 2006
Grant date	May 24, 2011
Priority date	—
Expiry date	Sep 3, 2028

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D487/04
WIPO fieldOrganic fine chemistry
WIPO sectorChemistry

Abstract

This invention comprises the novel compounds of formula (I)wherein R1, R2, R3, R4, R5, R6, Q1, Q2, X1, X2, Y and Z have defined meanings, having cell cycle kinase inhibiting enzymatic activity, their preparation, compositions containing them and their use as a medicine.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.